Back to resultsIron Deficiency Anemia in Childern With Liver Cirrhosis (IDA)
Primary Purpose
Iron Deficiency, Anaemia in Children, Liver Cirrhosis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
transferrin receptor concentration
Sponsored by
About this trial
This is an interventional diagnostic trial for Iron Deficiency, Anaemia in Children
Eligibility Criteria
Inclusion Criteria:
- all childern with liver cirrhosis in GIT and hepatology unit
Exclusion Criteria:
- Neonates less than one month
- childern with other liver diseases
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
transferrin receptor concentration
Arm Description
Prevelance of iron deficiency in this patients
Outcomes
Primary Outcome Measures
Prevelance of IDA in liver cirrhosis
To evaluate results
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03482076
Brief Title
Iron Deficiency Anemia in Childern With Liver Cirrhosis
Acronym
IDA
Official Title
Prevelance of Iron Deficiency Anemia in Liver Cirrhosis in Childern
Study Type
Interventional
2. Study Status
Record Verification Date
March 2018
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2019 (Anticipated)
Primary Completion Date
March 1, 2020 (Anticipated)
Study Completion Date
June 1, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Iron deficiency anemia is a common complication of liver cirrhosis in childern and may affects there life this study to improve the outcome of these patients
Detailed Description
Patients with cirrhosis are at risk of developing both IDA and anemia of chronic disease concomitantly, and there adverse effects can deteriorate general condition and affect of quality of life in these patients .Also because it is easier to correct IDA than anemia of chronic disease, so this study of the prevalence of IDA helping us in the diagnosis and treatment of IDA and can reduce the need for other diagnostic tests and improve the quality of life in patients with cirrhosis .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iron Deficiency, Anaemia in Children, Liver Cirrhosis
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
transferrin receptor concentration
Arm Type
Other
Arm Description
Prevelance of iron deficiency in this patients
Intervention Type
Diagnostic Test
Intervention Name(s)
transferrin receptor concentration
Intervention Description
Sandwich radio-imunoassay
Primary Outcome Measure Information:
Title
Prevelance of IDA in liver cirrhosis
Description
To evaluate results
Time Frame
two years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
all childern with liver cirrhosis in GIT and hepatology unit
Exclusion Criteria:
Neonates less than one month
childern with other liver diseases
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bahaa Khaled Mohamed
Phone
+201002755105
Ext
002
Email
drbahaakhaled@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Nagla Hassan Ibrahim
12. IPD Sharing Statement
Learn more about this trial
Iron Deficiency Anemia in Childern With Liver Cirrhosis
We'll reach out to this number within 24 hrs